跳至主要内容
临床试验/NCT03946423
NCT03946423撤回不适用

BAriaTric Surgery After Breast Cancer Treatment (BATS) - A Randomized Trial of Sleeve Gastrectomy Versus Lifestyle Intervention in Women Diagnosed With Early Stage Breast and With a BMI of ≥ 35

Masonic Cancer Center, University of Minnesota0 个研究点目标入组 40 人开始时间: 2026年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
入组人数
40
主要终点
Feasibility of Weight Loss Intervention

研究概览

简要总结

This is a feasibility study to gain an understanding of the willingness of women with a history of early stage breast cancer and current obesity to enroll in a weight-loss study, accept an assigned intervention (bariatric surgery with lifestyle intervention or lifestyle intervention alone), and comply with the study plan for 1 year. If there is successful enrollment in this study, the plan is to use what is learned in this study to design a larger, longer-term clinical trial to look at the effect of weight loss and incidence of cancer recurrence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 67 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of breast cancer in the previous 10 years and currently disease free.
  • Completion of breast cancer treatment (radiation, chemotherapy) at least > 6 months prior to enrollment
  • Body mass index (BMI) of ≥ 35 kg/m2, but < 50 kg/m
  • 18 through 67 years of age at enrollment
  • Deemed healthy enough to undergo bariatric surgery, if assigned intervention, as determined by a surgeon and documented in the medical record.
  • Must have insurance coverage with no exclusion for obesity related treatment or management of obesity related surgical complications - in general insurance coverage is available for persons with a BMI ≥ 35 kg/m
  • Anticipated ability to abide by study requirements demonstrated in part by, but not limited to, successful completion of run-in assessments.
  • Willingness to accept randomization into either interventional group.
  • Provides voluntary written consent prior to performance of any research related activities.

排除标准

  • Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.
  • Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.
  • Cardiac stress test indicating that surgery or lifestyle would not be safe.
  • 12-lead EKG indicating that surgery would not be safe.
  • Significant anemia (hemoglobin 1.0 g/dL or more below normal range) or history of coagulopathy.
  • History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection.
  • Gastric or duodenal ulcer in the past six months.
  • History of intra-abdominal sepsis except for uncomplicated appendicitis or diverticulitis more than six months prior to enrollment.
  • Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease.
  • Currently pregnant or nursing, or planning to become pregnant in the next 15 months.
  • History of alcohol, drug, or opioid dependency (excluding nicotine) in the past five years.
  • Active psychosocial or psychiatric problem that is likely to interfere with adherence to the protocol.
  • Deemed not an acceptable candidate by a trained psychologist.
  • Current participation in a conflicting research protocol.
  • Presence of any chronic or debilitating disease that would make adherence to the protocol difficult.
  • Gastroesophageal reflux disease requiring medications. History of endoscopy demonstrating esophagitis or Barrett's changes in the esophagus.
  • Any history of dysphagia.

研究组 & 干预措施

Sleeve Gastrectomy & Lifestyle Intervention

Experimental

干预措施: Bariatric Surgery with Sleeve Gastrectomy (Procedure)

Sleeve Gastrectomy & Lifestyle Intervention

Experimental

干预措施: Lifestyle Intervention (Behavioral)

Lifestyle Intervention

Active Comparator

干预措施: Lifestyle Intervention (Behavioral)

结局指标

主要结局

Feasibility of Weight Loss Intervention

时间窗: 1 Year

Feasibility for women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but \< 50 kg/m2.

Acceptability of Weight Loss Intervention

时间窗: 1 Year

Acceptability of women who were diagnosed with early stage breast cancer in the previous 10 years and have a body mass index (BMI) of ≥ 35 kg/m2 but \< 50 kg/m2.

次要结局

  • Weight Loss(1 Year)
  • Breast Cancer Recurrence(1 Year)
  • Cancer Related Mortality(1 Year)
  • Overall Mortality(1 Year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验